TY - JOUR
T1 - Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase
AU - Iribarne, Alexander
AU - Russo, Mark J.
AU - Davies, Ryan R.
AU - Hong, Kimberly N.
AU - Gelijns, Annetine C.
AU - Bacchetta, Matthew D.
AU - D'Ovidio, Frank
AU - Arcasoy, Selim
AU - Sonett, Joshua R.
N1 - Funding Information:
This work was supported in part by Health Resources and Services Administration contract 231-00-0115 and National Institutes of Health Training Grant 5T32HL007854-13 (Dr. Iribarne).
PY - 2009/4/1
Y1 - 2009/4/1
N2 - Background: In May 2005, the lung allocation score (LAS) was introduced as a means of allocating donor lungs in order to decrease wait-list mortality and prioritize candidates based on medical urgency and posttransplant survival. The purpose of this study was to assess changes in recipient wait-list times and mean LAS since the introduction of the LAS model. Methods: The United Network for Organ Sharing provided de-identified patient-level data. The study population consisted of all patients in the United States with a reported LAS (n = 3529) undergoing lung transplantation between May 7, 2005 and November 7, 2007. The study period was divided into 6-month intervals. The Kruskal-Wallis test was used to assess differences in variables with nonparametric distributions. The nonparametric trends test was used to determine significance of trends over time. Results: There was a significant decrease in wait-list time during the study period, while LAS among transplant recipients increased (p < 0.001). There was no significant change in FVC (49.3 ± 17.5%, p = 0.48) or pulmonary capillary wedge pressure (11.1 ± 5.8 mm Hg, p = 0.23); however, there was a significant increase in age (51.5 ± 13.9 years, p < 0.001) during the study period. When stratified by etiology, the LAS increased for both interstitial pulmonary fibrosis and COPD patients (p < 0.001). Moreover, the overall number of patients listed for transplantation as well as the LAS among transplant candidates increased (p <0.001). Conclusions: Two years after initiation of the LAS model, wait-list times continue to decrease while mean LAS continued to increase. This increase in LAS among transplant recipients was observed most notably in patients with interstitial pulmonary fibrosis and COPD, and reflected in an increased mean LAS at the time of listing.
AB - Background: In May 2005, the lung allocation score (LAS) was introduced as a means of allocating donor lungs in order to decrease wait-list mortality and prioritize candidates based on medical urgency and posttransplant survival. The purpose of this study was to assess changes in recipient wait-list times and mean LAS since the introduction of the LAS model. Methods: The United Network for Organ Sharing provided de-identified patient-level data. The study population consisted of all patients in the United States with a reported LAS (n = 3529) undergoing lung transplantation between May 7, 2005 and November 7, 2007. The study period was divided into 6-month intervals. The Kruskal-Wallis test was used to assess differences in variables with nonparametric distributions. The nonparametric trends test was used to determine significance of trends over time. Results: There was a significant decrease in wait-list time during the study period, while LAS among transplant recipients increased (p < 0.001). There was no significant change in FVC (49.3 ± 17.5%, p = 0.48) or pulmonary capillary wedge pressure (11.1 ± 5.8 mm Hg, p = 0.23); however, there was a significant increase in age (51.5 ± 13.9 years, p < 0.001) during the study period. When stratified by etiology, the LAS increased for both interstitial pulmonary fibrosis and COPD patients (p < 0.001). Moreover, the overall number of patients listed for transplantation as well as the LAS among transplant candidates increased (p <0.001). Conclusions: Two years after initiation of the LAS model, wait-list times continue to decrease while mean LAS continued to increase. This increase in LAS among transplant recipients was observed most notably in patients with interstitial pulmonary fibrosis and COPD, and reflected in an increased mean LAS at the time of listing.
KW - Lung allocation score
KW - Lung transplantation
KW - Organ allocation
KW - Wait-list time
UR - http://www.scopus.com/inward/record.url?scp=64749100815&partnerID=8YFLogxK
U2 - 10.1378/chest.08-2052
DO - 10.1378/chest.08-2052
M3 - Article
C2 - 19017874
AN - SCOPUS:64749100815
SN - 0012-3692
VL - 135
SP - 923
EP - 928
JO - Chest
JF - Chest
IS - 4
ER -